Clinical Trials Logo

Clinical Trial Summary

Heavy sedation or sleep is a common problem within the intensive care unit (ICU) using our standard intravenous medications. This commonly leads to confusion, low blood pressure, slow wake up and removal of the artificial breathing tube (extubation), which prolongs ICU stay. Using inhaled volatile anesthetic agents are likely to improve these patient outcomes. This unique project is the first North American study looking at using volatiles for patients who need longer-term ICU sedation. This project has excellent potential at lowering these complications and improving quality of care, which will lower patient ICU stay and healthcare costs.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Intubated Requiring Sedation for Greater Than 48 Hours

NCT number NCT01983800
Study type Interventional
Source University Health Network, Toronto
Contact
Status Completed
Phase N/A
Start date July 2013
Completion date November 2020